Everence Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$377K Hold
4,080
0.02% 474
2025
Q4
$417K Hold
4,080
0.02% 453
2025
Q3
$255K Hold
4,080
0.02% 674
2025
Q2
$212K Buy
+4,080
New +$182K 0.01% 734

Other funds holding GH

Everence Capital Management's GH Position: Q1 2026 in Review

Everence Capital Management held its Guardant Health (GH) position steady in Q1 2026 at 4,080 shares worth $377K. The position accounts for 0.02% of the portfolio, ranked #474.

Everence Capital Management first reported a position in GH in Q2 2025 and has held it in 4 quarters since. The position peaked at $417K in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Everence Capital Management held 4,080 shares of Guardant Health worth $377K as of Q1 2026.
  • Everence Capital Management left its Guardant Health share count unchanged in Q1 2026.
  • Guardant Health made up 0.02% of Everence Capital Management's portfolio in Q1 2026, its #474 holding.
  • Everence Capital Management first reported a position in Guardant Health in Q2 2025 and has held it in 4 quarters since.
  • Everence Capital Management's Guardant Health position peaked at $417K in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.